When, a handful of years ago, the U.S. and Canada changed their screening guidelines for cervical cancer, it was an acknowledgment that screenings for young women carried unintended harms. However, a ...
Background: Screening programmes are promoted to control transmission of and prevent female reproductive tract morbidity caused by genital chlamydia. The objective of this study was to examine the ...
Changes in how women are screened for cervical cancer mean they're getting Pap tests less often. But that may also mean young women are not getting tested for chlamydia, the most common sexually ...
The value of opportunistic chlamydia screening is being called into question. An epidemiologist at the University of Berne in Switzerland argues that claims about screening are not supported by ...
Sept. 14 (UPI) --All sexually active women and pregnant people age 24 years and younger should be screened for chlamydia and gonorrhea, according to new guidelines published Tuesday by JAMA. In ...
It is unlikely that single screening for chlamydia will prevent women developing pelvic inflammatory disease in the following year, according to new research. It is unlikely that single screening for ...
Please provide your email address to receive an email when new articles are posted on . The U.S. Preventive Services Task Force said today it recommends chlamydia and gonorrhea screening in all ...
Please provide your email address to receive an email when new articles are posted on . A novel community-based chlamydia screening program meant to reach young Black men in New Orleans proved to be ...
Americans looking to stay on top of their sexual health have a new at-home option available to them. Earlier this month, the Food and Drug Administration authorized the first home test for chlamydia ...
Sexually transmitted infections, or STIs, include both sexually transmitted diseases, known as STDs, and the many infections that don’t progress to disease. STIs are caused by more than 30 different ...
Our systematic review assessed evidence for the effectiveness of chlamydia screening in preventing chlamydia-associated morbidity or transmission of infection. Trial reporting quality was generally ...